Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Kerr

Showing results (81-90 of 218) with videos related to

Pageof 22
Sort By:
Hemodialysis International. International Symposium on Home Hemodialysis|April 4, 2007
Comparison between different dialysate calcium concentrations in nocturnal hemodialysisNigel D Toussaint, Kevan R Polkinghorne, Peter G Kerr, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 24, 2008
Determination and validation of aortic calcification measurement from lateral bone densitometry in dialysis patientsNigel D Toussaint, Kenneth K Lau, Boyd J Strauss, et al.
Palliative Medicine|August 23, 2005
Renal dialysis abatement: lessons from a social studyMichael Ashby, Corinne op't Hoog, Allan Kellehear, et al.
Nephrology (Carlton, Vic.)|August 23, 2011
Effect of exercise on albuminuria in people with diabetesKeng-Hee Koh, Bolonghoge Dayanath, James Cg Doery, et al.
Nephrology (Carlton, Vic.)|March 12, 2004
Cardiovascular risk in dialysis patients: a comparison of risk factors and cardioprotective therapy between 1996 and 2001Fiona Y F Chow, Kevan R Polkinghorne, Steven J Chadban, et al.
Lancet (London, England)|May 27, 2016
Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practicesBruce M Robinson, Tadao Akizawa, Kitty J Jager, et al.
Nephrology (Carlton, Vic.)|May 11, 2016
The effect of holiday haemodialysis treatments on patient mood, adverse symptoms and subjective wellbeing using the Big Red Kidney BusJane Sims, Paul N Bennett, Cherene Ockerby, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 12, 2010
Improving CKD-MBD management in haemodialysis patients: barrier analysis for implementing better practiceNigel D Toussaint, Eugenie Pedagogos, Jennifer Beavis, et al.
Nephrology (Carlton, Vic.)|March 12, 2004
Historical controlled trial of OKT3 versus basiliximab induction therapy in simultaneous pancreas-renal transplantationFiona Y F Chow, Kevan Polkinghorne, Alan Saunder, et al.
Regenerative Medicine|November 7, 2015
Human mesenchymal stem cells alter the gene profile of monocytes from patients with Type 2 diabetes and end-stage renal diseaseAndrea F Wise, Timothy M Williams, Stephen Rudd, et al.
Pageof 22

Showing results (81-90 of 218) with videos related to

Sort By:
Pageof 22
Hemodialysis International. International Symposium on Home Hemodialysis|April 4, 2007
Comparison between different dialysate calcium concentrations in nocturnal hemodialysisNigel D Toussaint, Kevan R Polkinghorne, Peter G Kerr, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 24, 2008
Determination and validation of aortic calcification measurement from lateral bone densitometry in dialysis patientsNigel D Toussaint, Kenneth K Lau, Boyd J Strauss, et al.
Palliative Medicine|August 23, 2005
Renal dialysis abatement: lessons from a social studyMichael Ashby, Corinne op't Hoog, Allan Kellehear, et al.
Nephrology (Carlton, Vic.)|August 23, 2011
Effect of exercise on albuminuria in people with diabetesKeng-Hee Koh, Bolonghoge Dayanath, James Cg Doery, et al.
Nephrology (Carlton, Vic.)|March 12, 2004
Cardiovascular risk in dialysis patients: a comparison of risk factors and cardioprotective therapy between 1996 and 2001Fiona Y F Chow, Kevan R Polkinghorne, Steven J Chadban, et al.
Lancet (London, England)|May 27, 2016
Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practicesBruce M Robinson, Tadao Akizawa, Kitty J Jager, et al.
Nephrology (Carlton, Vic.)|May 11, 2016
The effect of holiday haemodialysis treatments on patient mood, adverse symptoms and subjective wellbeing using the Big Red Kidney BusJane Sims, Paul N Bennett, Cherene Ockerby, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 12, 2010
Improving CKD-MBD management in haemodialysis patients: barrier analysis for implementing better practiceNigel D Toussaint, Eugenie Pedagogos, Jennifer Beavis, et al.
Nephrology (Carlton, Vic.)|March 12, 2004
Historical controlled trial of OKT3 versus basiliximab induction therapy in simultaneous pancreas-renal transplantationFiona Y F Chow, Kevan Polkinghorne, Alan Saunder, et al.
Regenerative Medicine|November 7, 2015
Human mesenchymal stem cells alter the gene profile of monocytes from patients with Type 2 diabetes and end-stage renal diseaseAndrea F Wise, Timothy M Williams, Stephen Rudd, et al.
Pageof 22